NEUROONE MEDICAL TECHNOLOGIE (NMTC)
US64130M2098 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.43M | 5.32M | 8.16M | 6.90M | 4.04M | |||
| Marketable Securities | N/A | 0.00 | 2.98M | N/A | N/A | |||
| Receivables | 555.64K | 0.00 | 30.00K | 50.00K | N/A | |||
| Inventories | 1.31M | 1.73M | 700.00K | 100.00K | N/A | |||
| Other Current Assets | 407.78K | 263.75K | 300.00K | 240.00K | 120.00K | |||
| Total Current Assets | 4.71M | 7.31M | 12.18M | 7.29M | 4.16M | |||
| Non-Current Assets | ||||||||
| PPE Net | 606.74K | 694.81K | 530.00K | 510.00K | 450.00K | |||
| Intangibles | 78.42K | 89.58K | 110.00K | 130.00K | 160.00K | |||
| Total Non-Current Assets | 685.16K | 784.38K | 640.00K | 650.00K | 600.00K | |||
| TOTAL ASSETS | 5.39M | 8.10M | 12.82M | 7.94M | 4.76M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.01M | |||
| Accrued Expenses | 759.62K | 1.11M | 720.00K | 640.00K | 510.00K | |||
| Accounts Payable | 780.84K | 685.10K | 930.00K | 530.00K | 760.00K | |||
| Other Current Liabilities | N/A | 0.00 | 1.46M | 10.00K | 70.00K | |||
| Total Current Liabilities | 1.54M | 1.79M | 3.10M | 1.18M | 2.36M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 55.28K | 120.00K | 200.00K | 340.00K | |||
| Total Non-Current Liabilities | 0.00 | 55.28K | 120.00K | 200.00K | 330.00K | |||
| TOTAL LIABILITIES | 1.54M | 1.85M | 3.22M | 1.38M | 2.69M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -68.89M | -62.69M | -50.83M | -40.83M | -30.88M | |||
| Additional Paid In Capital | 72.71M | 68.91M | 60.41M | 47.35M | 32.92M | |||
| Common Shares | 26.32K | 23.93K | 20.00K | 40.00K | 20.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 26.32M | 23.93M | 16.22M | 12.01M | 7.39M | |||
| Tangible Book Value per Share | 0.14 | 0.26 | 0.59 | 0.53 | 0.26 | |||
| Total Shareholders' Equity | 3.85M | 6.25M | 9.60M | 6.55M | 2.07M | |||
| TOTAL LIABILITIES AND EQUITY | 5.39M | 8.10M | 12.82M | 7.94M | 4.76M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.06 | 4.08 | 3.93 | 6.18 | 1.76 | |||
| Return On Assets (ROA) | -237.36% | -146.46% | -78.00% | -125.31% | -286.55% | |||
| Return On Equity (ROE) | -332.22% | -189.77% | -104.17% | -151.91% | -658.94% | |||
All data in USD